Pricing Log in Create free account
Friday 6 November 2026 Export IOSP’s income statement to Excel — free account

Innospec Inc.

IOSP Basic Materials Specialty Chemicals

Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.

Revenue
+7.17%
EPS
+146.7%
Free cash flow
−88.7%

Quarter to September 2026, against a year earlier

78.97 1.68 −2.08%
Market cap
$2.0B
P/E
13.9×
Fwd P/E
19.5×
Dividend yield
2.27%
F-score
7/9
Altman Z
4.75
Beneish M
−2.46
Dividend safety
79/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 0.57
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — 7 1 — — — — — — — —
Insider Ownership 1.55%

Capital & Financial Ratios $m

Size
Market Cap 1,950.00
Revenue ttm 1,873.80
Net income ttm 141.00
Free cash flow ttm 37.30
Net debt Q (251.90)
Valuation
P/E 13.92
Forward P/E 19.50
Price / sales 1.04
Forward P/S Powerpack
Price / FCF 52.15
Price / book 1.44
Financial health
Current ratio Q 2.95 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (19.38)
Growth
Revenue growth Q +7.17% (above 0%: growing)
Operating income growth Q +606.78% (above 0%: growing)
EPS, this year −6.41% (below 0%: weak)
EPS, next year A +21.71% (at or above 15%: strong)
Revenue, next year A +7.14%
EPS, past 5 yrs +32.12% (at or above 15%: strong)
EPS, next 5 yrs A +8.50%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.9×, against a ten-year median of 1.4×; over the ten years it ranged from 0.9× in 2026 to 2.1× in 2017.
P/E against its own 10 years 7.32%
10-year low 10-year high
P/S against its own 10 years 3.01%
10-year low 10-year high
P/B against its own 10 years 3.30%
10-year low 10-year high
EV/Sales against its own 10 years 3.08%
10-year low 10-year high
EV/FCF against its own 10 years 82.03%
10-year low 10-year high

Dividends raised every year since 2017

Yield
2.27%
Annual rate
1.79
Payout ratio
31.6%
Growth, 2017–25
+10.5%/yr
  1. 0.77 ’17
  2. 0.89 ’18 +16
  3. 1.02 ’19 +15
  4. 1.04 ’20 +2
  5. 1.16 ’21 +12
  6. 1.28 ’22 +10
  7. 1.41 ’23 +10
  8. 1.55 ’24 +10
  9. 1.71 ’25 +10
  10. 1.89 ’26e +11
paid forecast change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 204 289 293 252
Receivables 360 342 342 396
Inventory 300 301 329 362
Other 1 1 7 12
886 957 1,005 1,034
2023 2024 2025 Q'26
Payables 164 164 175 164
ST’ Debt — — — —
Other 5 5 12 7
372 371 360 351

Compound Annual Growth %

10y 5y 3y
Sales 5.79% 8.31% (3.26%)
Cash Flow 1.58% (1.06%) 19.18%
Earnings (0.25%) 32.36% (4.29%)
Book Value 8.21% 7.12% 8.61%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 1.26 Actual 1.29

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 1.26 1.50 Beat by 0.24
Q1 FY26 1.02 1.05 Beat by 0.03
Q2 FY26 1.05 1.27 Beat by 0.22
Q3 FY26 1.26 1.29 Beat by 0.03
Q4 FY26 1.41 — Reports 16 February 2027

EPS $

Mar Jun Sep Dec Year
’26 1.22 1.25 1.28 — —
’25 1.31 0.94 0.52 1.91 4.67
’24 1.65 1.24 1.33 (2.80) 1.42
’23 1.33 1.16 1.57 1.51 5.56
’22 1.46 1.29 1.55 1.02 5.32
’21 0.94 0.90 0.94 0.96 3.75
’20 1.34 (1.62) 0.51 0.91 1.16
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 453 491 474 — —
’25 441 440 442 456 1,778
’24 500 435 443 467 1,845
’23 510 480 464 495 1,949
’22 472 468 513 511 1,964
’21 340 355 376 413 1,483
’20 372 245 265 311 1,193
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 18 7 17 — —
’25 28 11 38 61 138
’24 81 5 74 26 185
’23 22 55 58 72 207
’22 (29) (7) 40 78 82
’21 23 (1) 3 69 93
’20 2 30 56 58 146
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 4 (9) 2 — —
’25 13 (6) 16 41 64
’24 66 (10) 62 5 123
’23 0 38 41 51 130
’22 (37) (16) 30 63 40
’21 12 (10) (5) 60 57
’20 (5) 23 48 50 116
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 883 1,307 1,477 1,513 1,193 1,483 1,964 1,949 1,845 1,778 1,874 +8.1% 1,905 2,016 — +6.5%
Gross margin, % 37.62 30.86 29.45 30.81 28.72 29.32 29.88 30.33 29.42 27.69 27.66 (9.9) pt
EBT 103 128 132 150 40 134 185 174 41 138 173 +3.3%
EBT margin, % 11.67 9.80 8.91 9.94 3.33 9.06 9.40 8.95 2.23 7.77 9.24 (3.9) pt
Net income 81 62 85 112 29 93 133 139 36 117 141 +4.1%
Per share, $
Per share, $ Revenue 36.81 54.12 60.53 61.81 48.57 60.19 79.22 78.42 74.02 71.46 76.07 +7.6%
Earnings 3.39 2.56 3.48 4.58 1.17 3.78 5.37 5.60 1.43 4.69 5.67 +3.7%
Cash flow 4.40 3.42 4.30 6.60 5.94 3.78 3.30 8.34 7.40 5.56 4.21 +2.6%
Capex (0.69) (1.33) (1.23) (1.27) (1.21) (1.47) (1.70) (3.10) (2.48) (2.99) (2.69) +17.7%
Free cash flow 3.71 2.09 3.07 5.33 4.73 2.31 1.60 5.24 4.92 2.57 1.51 (4.0%)
Book value 27.24 32.89 33.83 37.53 38.47 41.91 41.97 46.26 48.78 53.57 56.04 +7.8%
Shares, m 24 24 24 24 25 25 25 25 25 25 25 +0.4%
Valuation, ×
Valuation, × P/E 20.44 27.81 17.75 22.59 77.55 23.90 19.32 21.82 76.97 16.35 13.92 32.4
P/S 1.89 1.32 1.02 1.67 1.87 1.50 1.31 1.56 1.49 1.07 1.04 1.5
P/B 2.55 2.16 1.83 2.76 2.36 2.16 2.47 2.64 2.26 1.43 1.44 2.3
EV/Sales 2.08 1.42 1.08 1.68 1.80 1.42 1.24 1.46 1.34 0.92 0.92 1.4
EV/FCF 22.11 36.65 21.30 19.43 18.64 37.68 61.64 21.92 20.18 25.56 45.97 28.5
Cash, $m
Cash, $m Operating cash flow 106 83 105 162 146 93 82 207 185 138 104 +3.1%
Capex (16) (32) (30) (31) (30) (36) (42) (77) (62) (74) (66) +18.2%
Free cash flow 89 51 75 131 116 57 40 130 123 64 37 (3.6%)
Balance, $m
Balance, $m Working capital 258 300 367 327 314 392 467 514 585 645 683 +10.7%
Net debt 170 131 86 (17) (105) (142) (147) (204) (289) (292) (252) n/m
Shareholders’ equity 654 794 826 919 945 1,033 1,040 1,150 1,216 1,333 1,380 +8.2%
Returns, %
Returns, % ROA 7.36 4.77 5.90 7.63 2.00 6.27 8.38 8.40 2.07 6.54 7.68 (0.8) pt
ROIC 7.45 8.44 9.15 10.38 2.51 9.26 13.10 10.68 12.00 7.78 9.12 +0.3 pt
ROE 12.91 8.54 10.50 12.86 3.08 9.41 12.83 12.70 3.01 9.15 10.47 (3.8) pt
People
People Employees 1,800 1,900 2,000 2,000 1,900 1,900 2,100 2,400 2,450 2,450 — +3.5%
Revenue/emp, $m 0.49 0.69 0.74 0.76 0.63 0.78 0.94 0.81 0.75 0.73 — +4.4%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Innospec Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
WDFC WD-40 Company $3.0B 37.0× 32.3× +8.14% (above 0%: growing) −31.85% (below 0%: shrinking) +63.49% (above 0%: growing) 52.78% 10.78% Compare
FUL H. B. Fuller Company $2.7B 13.8× 11.7× +5.17% (above 0%: growing) +18.19% (above 0%: growing) −58.41% (below 0%: shrinking) 33.22% 12.07% Compare
KWR Quaker Houghton $2.6B 27.2× 21.6× +10.27% (above 0%: growing) −0.42% (below 0%: shrinking) −92.40% (below 0%: shrinking) 35.54% 8.97% Compare
NGVT Ingevity Corporation $2.2B 42.0× 18.4× −5.25% (below 0%: shrinking) n/m −136.08% (below 0%: shrinking) 44.25% 19.13% Compare
IOSP Innospec Inc. $2.0B 13.9× 19.5× +7.17% (above 0%: growing) +146.71% (above 0%: growing) −88.68% (below 0%: shrinking) 27.26% 8.80%
MTX Minerals Technologies Inc. $1.9B — (loss-making) — (loss-making) +4.23% (above 0%: growing) +2.80% (above 0%: growing) +19.04% (above 0%: growing) 23.28% 11.68% Compare
CC The Chemours Company $1.9B — (loss-making) — (loss-making) +3.01% (above 0%: growing) +223.80% (above 0%: growing) −12.50% (below 0%: shrinking) 15.00% 14.87% Compare
STDN Standard Nuclear Inc $1.8B — — — n/m — 67.21% (90.70%) Compare
SCL Stepan Company $1.5B 361× — (loss-making) +17.26% (above 0%: growing) +65.47% (above 0%: growing) −4.42% (below 0%: shrinking) 12.65% 3.75% Compare
Median of peers $2.1B 37.0× 20.0× +5.17% +10.50% −12.50% 34.38% 11.23%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 26 March 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 8.25m 5.50m 91.00
2024 13.22m 11.17m 128.00
2023 7.30m 10.14m 141.00
2022 7.89m 11.23m 116.00
2021 9.90m 6.60m 101.00
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

Innospec Inc. (IOSP) Latest News

4 Nov

Impact 3 · · GuruFocus.com
Impact 3 · · MarketBeat transcript
Impact 3 · · The Motley Fool transcript
Impact 3 · · Moby

3 Nov

Impact 3 · · GlobeNewswire

27 Oct

Impact 3 · · Zacks

16 Oct

Impact 3 · · Zacks

3 Sep

Impact 3 ·

12 Aug

Impact 3 · · The Motley Fool transcript

8 Aug

Impact 3 ·

7 Aug

Impact 3 ·

5 Aug

Impact 4 ·
Impact 3 · · MarketBeat transcript

4 Aug

Impact 3 ·

8 Jul

Impact 4 · · Trefis

13 May

Impact 3 · · Zacks

11 May

Impact 4 · · Simply Wall St.

8 May

Impact 4 · · The Motley Fool transcript
Impact 4 · · Moby
Impact 3 · · MarketBeat

7 May

Impact 3 · · Zacks
Impact 3 · · GlobeNewswire

30 Apr

Impact 3 · · Zacks

24 Apr

Impact 3 · · Simply Wall St.

20 Apr

Impact 4 · · The Motley Fool transcript

24 Mar

Impact 3 · · Zacks

17 Mar

Impact 3 · · Zacks
Impact 3 · · Zacks

9 Mar

Impact 4 ·
Impact 4 · · Zacks
stockrow.com/IOSP · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com